DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,191,376 | +23.3% | 4,802 | +19.2% | 0.09% | +28.6% |
| Q2 2023 | $966,480 | -2.1% | 4,027 | +2.8% | 0.07% | -6.7% |
| Q1 2023 | $986,989 | +71838.0% | 3,916 | -24.3% | 0.08% | -29.9% |
| Q4 2022 | $1,372 | -99.9% | 5,171 | -0.8% | 0.11% | -4.5% |
| Q3 2022 | $1,346,000 | -1.4% | 5,211 | -3.2% | 0.11% | +6.7% |
| Q2 2022 | $1,365,000 | -12.8% | 5,386 | +1.0% | 0.10% | -0.9% |
| Q1 2022 | $1,565,000 | -9.2% | 5,335 | +1.9% | 0.11% | -3.6% |
| Q4 2021 | $1,723,000 | +51.0% | 5,238 | +39.7% | 0.11% | +39.2% |
| Q3 2021 | $1,141,000 | +23.0% | 3,749 | +8.4% | 0.08% | +21.5% |
| Q2 2021 | $928,000 | +19.3% | 3,459 | 0.0% | 0.06% | +12.1% |
| Q1 2021 | $778,000 | +4.4% | 3,459 | +3.1% | 0.06% | -1.7% |
| Q4 2020 | $745,000 | +12.9% | 3,354 | +9.3% | 0.06% | 0.0% |
| Q3 2020 | $660,000 | -19.3% | 3,069 | -33.7% | 0.06% | -24.4% |
| Q2 2020 | $818,000 | +14.9% | 4,629 | -10.1% | 0.08% | 0.0% |
| Q1 2020 | $712,000 | +24.3% | 5,148 | +37.8% | 0.08% | +50.0% |
| Q4 2019 | $573,000 | +22.4% | 3,735 | +15.1% | 0.05% | +13.0% |
| Q3 2019 | $468,000 | +2.0% | 3,244 | +0.9% | 0.05% | 0.0% |
| Q2 2019 | $459,000 | +10.3% | 3,216 | +1.9% | 0.05% | +9.5% |
| Q1 2019 | $416,000 | +28.0% | 3,156 | 0.0% | 0.04% | +13.5% |
| Q4 2018 | $325,000 | -0.9% | 3,156 | +4.4% | 0.04% | +15.6% |
| Q3 2018 | $328,000 | +8.6% | 3,023 | -1.3% | 0.03% | 0.0% |
| Q2 2018 | $302,000 | +17.1% | 3,063 | +16.0% | 0.03% | +14.3% |
| Q1 2018 | $258,000 | +0.8% | 2,640 | -4.3% | 0.03% | -6.7% |
| Q4 2017 | $256,000 | – | 2,760 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |